University of California San Francisco
Give to UCSF
A new study of autism risk genes by UCSF and UC Berkeley scientists implicates disruption in prenatal neurogenesis – a process in which specialized “progenitor” cells give rise to new brain cells – in the development of autism spectrum disorders.
The new center will provide an integrated platform for basic and clinical research, bringing together vascular biology, immunology, and neuroscience.
A new study shows how minority patients are effectively disqualified from receiving the latest cystic fibrosis drugs approved only for people with mutations more common among white patients.
The vaccination site builds off previous work with Unidos en Salud to bring COVID-19 testing to the Mission District.
A UCSF team has engineered a tiny antibody capable of neutralizing the coronavirus.
As its supply of COVID-19 vaccines increases, UC San Francisco is expanding its vaccination efforts to those most at risk – the elderly and health care workers in the community
We posed the most common COVID-19 vaccine quandaries to Bryn Boslett, MD, an infectious disease expert who is leading the vaccination effort at UCSF. She explains why mRNA vaccines won’t affect your DNA, which allergies pose a risk, what 95 percent efficacy really means, and more.
UCSF researchers found that alcohol has an immediate effect on the heart in patients with atrial fibrillation, the most common life-threatening heart-rhythm disorder.
In two preclinical models of COVID-19, plitidepsin showed a 100-fold reduction in viral replication in the lungs and demonstrated an ability to reduce lung inflammation.
A nationally recognized leader in health care, Laret joined UCSF in 2000.
Patients with severe COVID-19 produce antibodies that paradoxically shut down their immune system’s virus-fighting response just when they need it most.
The Regents’ vote follows more than two years of robust community engagement spanning 28 public meetings to develop the CPHP, which reflects input from hundreds of stakeholders inside and outside UCSF.
Scientific presentations will include advances in understanding the immune response, and precision medicine-driven development of new diagnostics, therapeutics, vaccines, and population health strategies.
Few would have predicted last January that a pandemic would upend our daily lives. But one grueling year in, UCSF experts have a clearer view of the path ahead.
“It’s too soon to know if this variant will spread more rapidly than others," said Erica Pan, MD, MPH, State Epidemiologist for the California Department of Public Health.
Depression is among the most common psychiatric disorders, affecting as many as 264 million people worldwide and leading to hundreds of thousands of deaths per year. But as many as 30 percent of patients do not respond to standard treatments such as medication or psychotherapy.
UCSF, the San Francisco Building and Construction Trades Council, and Herrero Boldt Webcor have announced a Community Workforce Agreement that will promote collaboration between the University, labor unions and construction firms during the construction of the new hospital at UCSF Helen Diller Medical Center at Parnassus Heights.
Scientists at UCSF have developed ReScan, an innovative new serological test that employs a specialized version of the technique known as phage display.
A mutated version of the novel coronavirus has been making the news for being more contagious. We asked UCSF infectious disease expert Charles Chiu, MD, PhD, how the new variant emerged, whether available vaccines will still work, and what we need to do now.
A team of researchers has identified for the first time the neurons that are among the first victims of Alzheimer’s disease.
UCSF Medical Center has begun administering second doses of the Pfizer COVID-19 vaccine to frontline employees who are at highest risk of exposure to COVID-19 at work.
